p.98 抽出テキスト

668. Kanbay A, Inonu H, Solak Y, et al. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med 2014; 25: 471-476. PMID: 24793835 669. El Solh AA, Saliba R, Bosinski T, et al. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006; 27: 997-1002. PMID: 16707395 670. Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail 2016; 4: 116-125. PMID: 26682790 671. Oldenburg O, Wellmann B, Buchholz A, et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J 2016; 37: 1695-1703. PMID: 26612581 672. Arzt M, Oldenburg O, Graml A, et al. SchlaHF Investigators. Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction the SchlaHF Registry. J Am Heart Assoc 2017; 6: e 005899. PMID: 29187390 673. Haruki N, Floras JS. Sleep-Disordered Breathing in Heart Failure ― A Therapeutic Dilemma. Circ J 2017; 81: 903- 912. PMID: 28539541 674. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: Pathophysiologic and therapeutic implications. J Am Coll Cardiol 2011; 57: 119-127. PMID: 21211682 675. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: Implications for cardiac and vascular disease. 14532320 JAMA 2003; 290: 1906-1914. PMID: 14532320 676. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046- 1053. PMID: 15781100 677. Carr GE, Mokhlesi B, Gehlbach BK. Acute cardiopulmonary failure from sleep-disordered breathing. Chest 2012; 141: 798-808. PMID: 22396567 678. Azarbarzin A, Sands SA, Taranto-Montemurro L, et al. The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure. Chest 2020; 158: 739-750. PMID: 32298733 679. Kasai T, Narui K, Dohi T, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008; 133: 690- 696. PMID: 18198253 680. Solin P, Kaye DM, Little PJ, et al. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest 2003; 123: 1119-1126. PMID: 12684302 681. Spaak J, Egri ZJ, Kubo T, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327-1332. PMID: 16286569 682. Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo- Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med 2015; 373: 1095-1105. PMID: 26323938 683. Roebuck T, Solin P, Kaye DM, et al. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004; 23: 735-740. PMID: 15176689 684. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440. PMID: 10086966 685. Khayat R, Abraham W, Patt B, et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail 2012; 18: 534- 540. PMID: 22748486 686. Bitter T, Westerheide N, Prinz C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61-74. PMID: 20846992 687. Kwon Y, Koene RJ, Kwon O, et al. Effect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol 2017; 10: e004609. PMID: 28213507 688. Khayat R, Jarjoura D, Porter K, et al. Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J 2015; 36: 1463-1469. PMID: 25636743 689. Ishiwata S, Kasai T, Sato A, et al. Prognostic effect of sleepdisordered breathing on hospitalized patients following acute heart failure. Clin Res Cardiol 2022; 111: 663- 672. PMID: 34761310 690. Arzt M, Young T, Finn L, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006; 166: 1716-1722. PMID: 16983049 691. Kasai T, Taranto Montemurro L, Yumino D, et al. Inverse relationship of subjective daytime sleepiness to mortality in heart failure patients with sleep apnoea. ESC Heart Fail 2020; 7: 2448-2454. PMID: 32608195 692. Aurora RN, Patil SP, Punjabi NM. Portable Sleep Monitoring for Diagnosing Sleep Apnea in Hospitalized Patients With Heart Failure. Chest 2018; 154: 91-98. PMID: 29684317 693. Yumino D, Wang H, Floras JS, et al. Relation of periodic leg movements during sleep and mortality in patients with systolic heart failure. Am J Cardiol 2011; 107: 447-451. PMID: 21257013 694. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361- 366. PMID: 14597482 695. Sun H, Shi J, Li M, et al. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS One 2013; 8: e62298. PMID: 23650511 696. Damy T, Margarit L, Noroc A, et al. Prognostic impact of sleepdisordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 2012; 14: 1009-1019. PMID: 22730336 697. Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. J Am Coll Cardiol 2017; 69: 841-858. PMID: 28209226 698. Khan SU, Duran CA, Rahman H, et al. A meta-analysis of continuous positive airway pressure therapy in prevention of cardiovascular events in patients with obstructive sleep apnoea. Eur Heart J 2018; 39: 2291-2297. PMID: 29069399 699. Lyons OD, Floras JS, Logan AG, et al. ADVENT-HF Investigators. Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial. Eur J Heart Fail 2017; 19: 579-587. PMID: 28371141 700. Sharma BK, Bakker JP, McSharry DG, et al. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: A systematic review and meta-analysis. Chest 2012; 142: 1211- 1221. PMID: 22722232 701. Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 2012; 35: 17-40. PMID: 22215916 702. Kasai T, Usui Y, Yoshioka T, et al. JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 2010; 3: 140-148. PMID: 19933407 703. Kasai T, Kasagi S, Maeno K, et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC Heart Fail 2013; 1: 58- 63. PMID: 24621799 704. Yoshihisa A, Shimizu T, Owada T, et al. Adaptive servo ventilation improves cardiac dysfunction and prognosis in chronic heart failure patients with Cheyne-Stokes respiration. Int Heart J 2011; 52: 218-223. PMID: 21828947 705. Koyama T, Watanabe H, Igarashi G, et al. Effect of short-duration adaptive servo-ventilation therapy on cardiac function in patients with heart failure. Circ J 2012; 76: 2606-2613. PMID: 22850337 706. Yoshihisa A, Suzuki S, Miyata M, et al. ‘A single night’ beneficial effects of adaptive servo-ventilation on cardiac overload, sympathetic nervous activity, and myocardial damage in patients with chronic heart failure and sleep-disordered breathing. Circ J 2012; 76: 2153-2158. PMID: 22785005 707. Koyama T, Watanabe H, Tamura Y, et al. Adaptive servo-ventilation therapy improves cardiac sympathetic nerve activity in patients with heart failure. Eur J Heart Fail 2013; 15: 902- 909. PMID: 23504594 708. Joho S, Oda Y, Ushijima R, et al. Effect of adaptive servoventilation on muscle sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. J Card Fail 2012; 18: 769-775. PMID: 23040112 709. Ushijima R, Joho S, Akabane T, et al. Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle sympathetic nerve activity in patients with heart failure. Circ J 2014; 78: 1387-1395. PMID: 24705391 710. Harada D, Joho S, Oda Y, et al. Short term effect of adaptive servo-ventilation on muscle sympathetic nerve activity in patients with heart failure. Auton Neurosci 2011; 161: 95- 102. PMID: